Endogenex, Inc.
Clinical trials sponsored by Endogenex, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Electric zaps to the gut could help control type 2 diabetes Results expected Feb 2027 (estimated)
-
New diabetes device put to the test in Real-World study
Disease control By invitation onlyThis study looks at the safety and performance of the Endogenex System in 50 adults with type 2 diabetes. Participants previously received a sham (fake) procedure in an earlier study. The main goal is to track any serious side effects related to the device or procedure.
Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Electric zaps to the gut could help control type 2 diabetes
Disease control OngoingThis study tests a device called ReCET that delivers gentle electric pulses to the first part of the small intestine. The goal is to trigger cell regeneration and improve blood sugar control in people with type 2 diabetes who are not on insulin. Participants are randomly assigned…
Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
New registry tracks Real-World safety of diabetes device
Knowledge-focused By invitation onlyThis registry will follow 500 people with type 2 diabetes who have already been treated with the Endogenex System. The goal is to collect long-term safety data and see how the device performs in everyday use. Participants must agree to share their medical records and attend follo…
Sponsor: Endogenex, Inc. • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC